Accéder au contenu
Merck
Toutes les photos(2)

Key Documents

Autres documents

F9397

Sigma-Aldrich

Flutamide

Synonyme(s) :

2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(2)

About This Item

Formule empirique (notation de Hill):
C11H11F3N2O3
Numéro CAS:
13311-84-7
Poids moléculaire :
276.21
Numéro CE :
236-341-9
Numéro MDL:
MFCD00072009
Code UNSPSC :
51111800
ID de substance PubChem :
24278446
Nomenclature NACRES :
NA.77

Auteur

Schering Plough

Chaîne SMILES 

CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O

InChI

1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)

Clé InChI

MKXKFYHWDHIYRV-UHFFFAOYSA-N

Informations sur le gène

human ... AR(367)
mouse ... Ar(11835)
rat ... Ar(24208)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Application

Flutamide has been used to effect of testosterone on Glial cell-derived neurotrophic factor (Gdnf) mRNA production in vitro. It has also been used to study the effects of flutamide on anogenital distance and nipple retention.

Actions biochimiques/physiologiques

Flutamide is a non-steroidal anti-androgen drug. It consists of a nitroaromatic structure. Flutamide is a potent competitor of testosterone and dihydrotestosterone receptors. It is a potent hepatotoxin.

Caractéristiques et avantages

This compound was developed by Schering Plough. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Pictogrammes

Health hazardExclamation markEnvironment
GHS08,GHS07,GHS09

Mention d'avertissement

Warning

Mentions de danger

H302,H351,H361,H373,H411

Classification des risques

Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 2 - Repr. 2 - STOT RE 2

Organes cibles

Liver

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Équipement de protection individuelle

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 8

1 of 8

Finasteride ≥98% (HPLC), powder

Sigma-Aldrich

F1293

Finasteride

VPC-13566 ≥98% (HPLC)

Sigma-Aldrich

SML1886

VPC-13566

Fulvestrant >98% (HPLC)

Sigma-Aldrich

I4409

Fulvestrant

Abiraterone acetate ≥98% (HPLC)

Sigma-Aldrich

SML1527

Abiraterone acetate

Bicalutamide Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1678

Bicalutamide

Flutamide for system suitability European Pharmacopoeia (EP) Reference Standard

Y0001591

Flutamide for system suitability

PF-998425 ≥98% (HPLC)

Sigma-Aldrich

PZ0131

PF-998425

Flutamide United States Pharmacopeia (USP) Reference Standard

USP

1285851

Flutamide

Shuchen Gu et al.
Cellular signalling, 25(1), 66-73 (2013-01-15)
Actin cytoskeleton reorganization initiated by testosterone conjugates through activation of membrane androgen receptors (mAR) has recently been reported in colon tumor cells. This mAR-induced actin reorganization was recognized as a critical initial event, controlling apoptosis and inhibiting cell migration. The
N A Spry et al.
Prostate cancer and prostatic diseases, 16(1), 67-72 (2012-08-22)
To examine changes to whole body and regional lean mass (LM) and fat mass (FM) over 33 months of intermittent androgen suppression therapy (IAST). Phase II cohort study of 72 prostate cancer patients without metastatic bone disease. Patients received flutamide
Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat
Hass U, et al.
Environmental Health Perspectives, 115(Suppl 1), 122-128 (2007)
Flutamide-induced hepatotoxicity: ethical and scientific issues
Giorgetti R, et al.
European Review for Medical and Pharmacological Sciences, 21(1 Suppl), 69-77 (2017)
Palakkil Mavilavalappil Sandeep et al.
Metabolic syndrome and related disorders, 13(6), 248-254 (2015-04-29)
Polycystic ovary syndrome (PCOS) is a major hyperandrogenic disorder. Many drugs prescribed specifically to treat PCOS have side effects; however, previous studies suggest that natural therapeutics including botanicals may be less invasive and equally effective for the management of PCOS.
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique